Close

Amgen (AMGN) Announces XGEVA vs. Zoledronic Acid Study Met Primary Endpoint; Secondary Endpoints Missed

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BA
8. BSX
9. SNAP
10. PI


Go back to Amgen (AMGN) Announces XGEVA vs. Zoledronic Acid Study Met Primary Endpoint; Secondary Endpoints Missed
Amgen Inc (NASDAQ: AMGN) Delayed: 269.15 -3.86 (1.41%)
Previous Close $273.01    52 Week High $176.85 
Open $273.45    52 Week Low $133.64 
Day High $274.35    P/E 40.53 
Day Low $267.24    EPS $6.64 
Volume 1,173,055